By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.
Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...
This week, Bobbi Conner talks with MUSC's Dr. Sarah Breevoort about early diagnosis and treatment for ALS (Lou Gehrig’s ...
With a counseling degree, you’ll transform the way others approach hope and healing. Discover what’s next. In Bethel's M.A. in Counseling program, you’ll prepare to become an effective counselor who ...
In recent years, significant therapeutic advances across multiple disease areas—including immuno-oncology, metabolic diseases such as type 2 diabetes and ...
Given that more than a million people applied to take part in the London Marathon this year, you might assume that 26.2 miles is the UK’s most popular race distance. But you’d be wrong. It’s the half ...
News Medical on MSN
Predictive Lab Test for Cardiac Events Still Rare but Increasing
Despite increasing awareness, testing remains rare. National guidelines currently recommend at least one lifetime Lp (a) test ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback